https://ar-13324inhibitor.com/....an-assessment-of-the
At one year, 135 (64%) patients showed HPR, and 76 (36%) failed to. There clearly was a substantial increase in ischemic endpoint events including cardiovascular death, non-fatal myocardial infarction, stroke/transient ischemic assault in patients with than without HPR at 1 year (hazard ratio[HR], 2.68, 95% confidence interval[CI], 1.06-6.77, p=0.036). Nevertheless, the occurrence of any Bleeding Academic analysis Consortium (BARC) hemorrhaging was notably low in the HPR group (HR, 0.11
Like
Comment
Share
